Institutionelle bei Idec Pharma

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Citigroup Inc. 15,183,879 $580,631,532
Morgan Stanley 7,994,755 $305,719,431
BB Biotech Ag 4,682,000 $179,039,680
Putnam Investment Management, Inc. 4,370,071 $167,111,515
American Express Financial Corp 4,268,698 $163,235,011
Oppenheimerfunds, Inc. 4,048,265 $154,805,653
FMR Corporation (Fidelity Management & Research Corp) 18,819,494 $719,657,450
Allianz Dresdner Asset Management Of America, Inc. 3,003,298 $114,846,115
Barclays Bank Plc 2,831,648 $108,282,219
Price (T.Rowe) Associates 2,795,204 $106,888,600

Topliste der investierten Fonds
Smith Barney Aggressive Growth Fund Inc. 4,800,000 $183,552,000
Fidelity Aggressive Growth Fund 4,717,250 $180,387,640
Fidelity Select Portfolios - Biotechnology 3,371,140 $128,912,393
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 3,192,680 $122,088,083
Fidelity Otc Portfolio 1,570,000 $60,036,800
Growth Fund of America Inc 1,558,500 $59,597,040
Vanguard Specialized-Health Care Fund 1,560,000 $59,654,400
Morgan Stanley American Opportunities Fd 1,389,410 $53,131,038
Fidelity Mid-Cap Stock Fund 1,383,420 $52,901,980
Merrill Lynch Fundamental Growth Fund 1,320,000 $50,476,800